官方服务：
资源简介：
Effect of prostacyclin in ovarian carcinoma
应用场景：
创建时间：
2022-12-16
相关数据集
Pharmacological Mechanisms of Kirenol Against Ovarian Carcinoma: A Network Pharmacology and Experimental Validation Study in vitro
Materials and methodsNetwork pharmacologyPrediction and screening of kirenol targetsThe potential target of kirenol was forecasted using the SwissTarget Prediction database (http://www.swisstargetpred
DataCite Commons2025-04-27 更新120
Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
We examined the transcriptional changes modulated by ESR2 agonist liquiritigenin by perfroming global transcriptome analysis. ES2 cells were treated with either vehicle or liquiritigenin for 24 h and
NIAID Data Ecosystem60
ARID1A-mutated ovarian cancers depend on HDAC6 activity
ARID1A, encoding a subunit of the SWI/SNF chromatin remodeling complex, is the most mutated epigenetic regulator in human cancers. ARID1A and TP53 mutations are typically mutually exclusive. Therap
NIAID Data Ecosystem40
Fig8
Schematic illustration of eNK-EXO enhance the anti-tumor effects against ovarian cancer by delivering chemotherapeutic drugs and reactivating NK cell functions
NIAID Data Ecosystem80
Complete list of synlet interactions addressed by novel drug combinations.
The full list of addressed synlet interactions as well as the respective novel proposed drug combinations are given in the S1 Table. Synlet interactions are sorted in descending order based on the sum
NIAID Data Ecosystem50
